Popular search terms:

We're Bigger and Better Than Ever!

CSL Behring is a proud part of the CSL family, which now includes CSL Plasma, CSL Seqirus and CSL Vifor.

Learn More About Us

Jason, who has von Willebrand Disease, sits at a table with art supplies.

Meet Jason, a Plasma P.A.L.

The 27-year-old lives with von Willebrand Disease, a bleeding disorder it took years to diagnose. He makes regular visits to …

27 Mar 2023

Plasma Fractionation Facility Opens in Germany

For the second time in four months, the global biotech company is launching a new manufacturing facility with expanded capaci…

24 Mar 2023

Explainer: What Is a Functional Movement Analysis?

CSL Behring employees in Marburg, Germany, recently took advantage of a voluntary functional movement analysis, which assesse…

23 Mar 2023

March is National Bleeding Disorders Awareness Month

What You Don't Know About Bleeding Disorders

We asked people who know bleeding disorders best to tell us what these conditions are like in real life for those who live wi…

22 Mar 2023

Growing Older With Hemophilia

As hemophilia patients live longer lives, watch out for these three health conditions, according to a recent Hemophilia Feder…

21 Mar 2023

PRWeek Healthcare Conference Awards 2023 Finalist

Recognition for CSL's Communications Function

The function earned a nomination in the PRWeek Healthcare Awards in the category of Outstanding In-House Team. Fellow nominee…

20 Mar 2023

What's Next for Rare Disease Advocates?

Global Genes’ NEXT Report shares stories of self-starters in the rare disease community who are taking the initiative and lea…

17 Mar 2023

Reimagining Rare Together - Rare Impact Awards from the National Organization for Rare Disorders May 4-6, 2023

CSL Behring Makes a Rare Impact

The National Organization for Rare Disorders will honor CSL Behring with a Rare Impact Award in May.

16 Mar 2023